The article focuses on the recognition of frailty as warning sign for mortality, cognitive decline, and chronic illnesses. Topics discussed include the relations between chronic inflammatory markers and mitochondrial DNA, the impact of mesenchymal stem cells on the frailty phenotype, and the activation of the chronic inflammatory pathway.